BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+85.5%
5Y CAGR+124.8%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+85.5%/yr
Annual compound
5Y CAGR
+124.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
57.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $473.81M | +117.3% |
| 2024 | $218.02M | +3079.6% |
| 2023 | $6.86M | -90.8% |
| 2022 | $74.21M | +11.4% |
| 2021 | $66.60M | +707.4% |
| 2020 | $8.25M | -78.3% |
| 2019 | $38.06M | - |
| 2018 | $0.00 | +100.0% |
| 2017 | $-260000.00 | - |